The author reports his Research Group and the Iberian Multicentre Group experiences in order to find a therapeutical solution for the rupture of the ventricular free wall (WR) in acute myocardial infarction (AMI). The study includes seven phases. In a 1st phase of the study it was confirmed, by retrospective analysis, that the WR in AMI was a frequent event. In the 2nd phase of the investigation proceeding it was decided to set up a prospective anatomical and clinical protocol to evaluate this entity. Necropsic studies were performed in 71% of the patients who died in UTIC and we verified an incidence of 26% of WR in AMI. The WR were not uniform, in what concerns necropsic and clinical findings. The 3rd phase of the study consisted in the discrimination not only of the anatomo-pathological pictures but also of the clinical ones of this entity. Under the morphological point of view four types of rupture were described and the patient profile with AMI who has WR risk was defined. During the 4th phase of the study the progressive WR was identified and defined which was found in approximately 50% of the cases, corresponding the WR to a terminal accident with an average duration of 4 hours in the so called type 2, and of 10 h 50 min in the so called type 3. In the 5th phase of the study the objective consisted in the evaluation of the importance of the Ecocardiography and of the Hemodynamical Examinations with Swanz-Ganz catheter in the WE diagnosis. Based on the referred criteria it was possible to operate on 37 cases in Madrid (57% of mortality) and 6 cases in Lisbon (2 deaths). We are now in the 6th phase of the study. It consists in the diffusion of a medical and surgical approach fluxogram of patients with WR in AMI. In the end of this Editorial the author discusses the role of arterial hypertension, physical activity, anticoagulant and fibrinolitic therapeutics, microcirculation characteristics haemorheological changes in the WR genesis during AMI.

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...